The 3rd Annual AI-ML: Drug Discovery & Development Summit is the industry’s definitive guide to translating the wealth of tech available to successful, efficacious and efficient R&D processes. With 3 days of real-world case studies, this summit will provide the roadmap to augmented R&D decision making with reduced failure rates, increased speed and improved margins.

This year’s summit will take a deeper look at:

•  Target, pathway and molecule selection – identifying which will treat individual disease indications better
•  Predictive preclinical models – knowing from the beginning how drug candidates will react when administered to in vivo and in vitro models
•  Identification of the patients who will react best to the treatment with minimal side effects for a guaranteed successful clinical trial